ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1265

Patient Portal Awareness and Utilization Across Diverse Rheumatology Populations

Emily Gutowski1, Joshua Novack2, Allyson Covello2, Philip Carlucci3, Scott Goldberg1, Mary Guan4, Marcus Hines2, Elliot Philips2, Michael Pillinger5 and Sara Stream6, 1New York University Grossman School of Medicine, Brooklyn, NY, 2New York University Grossman School of Medicine, New York, NY, 3New York University School of Medicine, New York, NY, 4NYU Grossman SOM, Brooklyn, NY, 5New York University Grossman School of Medicine, New York,, NY, 6New York University Grossman School of Medicine, Great Neck, NY

Meeting: ACR Convergence 2025

Keywords: Access to care, Disparities, education, medical, education, patient, Surveys

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1248–1271) Patient Outcomes, Preferences, & Attitudes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Patients with rheumatic diseases face complex and chronic diagnoses that require close monitoring and frequent communication with their providers. Given increasing challenges to in-person medical care, including decreased time for clinic visits, physician shortages, and scheduling difficulties, online patient portals serve as important tools to engage patients in their care, allowing them to review test results, schedule appointments, and communicate with physicians. To identify barriers to portal use, we evaluated rheumatology patients’ awareness, use, and perceptions of patient portals across three clinical sites: a public safety net hospital, private academic teaching hospital and Veterans Affairs (VA) Hospital.

Methods: We conducted a cross-sectional, survey-based study in outpatient adult rheumatology clinics in three hospitals. During routine visits, surveys were distributed to patients in English or Spanish. Surveys assessed demographics, educational background, familiarity with each hospital system’s portal, frequency and reason for portal use, and interest in learning more. Informational handouts on portal capabilities and sign-up instructions were provided.

Results: 139 patients completed the survey: 50 from the VA, 15 from the private hospital and 74 from the public hospital. The average age was 53.1; 48.2% of respondents were male. Hispanic identity (46.8%) was most common. English was the primary language for 77%. The most reported highest education level was high school (Table 1).93.5% of all patients surveyed were aware of their patient portal, and 71.9% reported using their portal at least once a month. Portal awareness and use declined with age: patients 65 and over were less likely to have internet access or use portals, including a plurality who never used them (Figure 1). Older patients also reported more difficulty navigating portals (Figure 2A). Use varied by hospital, with highest use at the public hospital and lowest at the VA (Figure 2B). At the public hospital, higher educational attainment was associated with increased computer and internet access, whereas computer and internet access were nearly universal at the private hospital, regardless of education.

Conclusion: While awareness of patient portals was high across all sites, actual use was far lower and varied by age and hospital site. Patients 65 and over had the lowest frequency of use, which may be related to reduced access to technology and less favorable attitudes towards portals. Internet and computer access was not universal and varied with educational level, suggesting that access may be a limiting factor. Our findings highlight the need for targeted interventions, such as educational and technical support, as well as alternative communication strategies in those who are unable to utilize patient portals. These efforts would help to increase patient engagement in their medical care, ultimately improving outcomes in rheumatology.

Supporting image 1Table 1. Demographic characteristics of survey respondents.

Supporting image 2Figure 1. Awareness (A) and use frequency (B) of patient portal by age. Answers for panel A refer to “I am aware of my patient portal.”

Supporting image 3Figure 2. Difficulty using patient portal by age (A) and portal usage by health system (B). Answers refer to “I have trouble using my patient portal” and “I find my patient portal useful for my needs.”


Disclosures: E. Gutowski: Run the List, 12, Creator of podcast (runs ads including those for medical tools, e.g., Open Evidence); J. Novack: None; A. Covello: None; P. Carlucci: None; S. Goldberg: None; M. Guan: None; M. Hines: None; E. Philips: None; M. Pillinger: Amgen, Federation Bio, Fortress Biotech, Scilex, and SOBI, 2, Convergence Bio, 2; S. Stream: None.

To cite this abstract in AMA style:

Gutowski E, Novack J, Covello A, Carlucci P, Goldberg S, Guan M, Hines M, Philips E, Pillinger M, Stream S. Patient Portal Awareness and Utilization Across Diverse Rheumatology Populations [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/patient-portal-awareness-and-utilization-across-diverse-rheumatology-populations/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patient-portal-awareness-and-utilization-across-diverse-rheumatology-populations/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology